Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
Alzheimer’s Drugs Eyed by Investors Seeking Obesity-Like Gains
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
The Misconceptions About Anavex Life Sciences' Blarcamesine Phase 2b/3 Trial In Alzheimer's Disease
Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...
Alzheimer’s total prevalent cases to reach 22.51 million in 8MM in 2033
GlobalData analysis suggests that China will lead with the highest number of prevalent cases of Alzheimer’s disease in 2033.
Armed robbery in Revesby1h
Cognitive Tests May Aid Early Lewy Body Dementia ID
The third most common form of dementia is often mistaken for Alzheimer's despite different treatment needsCognitive profiles ...
Little-known Alzheimer's sign that could appear in the way you walk
This specifically involved distinguishing between Alzheimer's disease, the most common form of dementia, and Lewy body ...
How a person walks may flag Alzheimer's or other type of dementia
The way in which we walk might hold the key to diagnosing Alzheimer's, or other types of dementia. Ground-breaking research ...
Hosted on MSN1h
The Stages of Alzheimer's Disease
Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...
Verywell Health on MSN4h
What Happens to Your Brain When You Take These 16 Supplements?
While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...
How Alzheimer's could be diagnosed a DECADE earlier following huge study of blood proteins
Researchers believe a simple blood test could flag people who are in the early stages of Alzheimer's, as well as spotting ...
pharmaphorum20h
TauRx sees path to FDA filing for tau-targeting Alzheimer's drug
TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD ... to take place within four years in a new position paper. Eli Lilly has another approval for its anti-amyloid ...